Efficacy and Safety of Triple Combination Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Patients With Cystic Fibrosis: A Meta-Analysis of Randomized Controlled Trials.

Front Pharmacol · 2022 · PMC8964016 · PMID 35359862

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

In conclusion, the triple therapy combination had highly significant efficacy and safety in treating CF, as compared with placebo or active control, for patients with F/F, F/MF, F/RF or F-gating mutations.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.